Blessing A. Adeyeye | McCarter & English, LLP

Blessing Adeyeye’s practice focuses on securities law, mergers and acquisitions, and corporate finance.

Blessing represents issuers, underwriters, and investors, both domestic and foreign, in a broad range of public and private corporate finance transactions, including initial public offerings, shelf registrations, registered direct offerings, private investments in public equity (PIPEs), private placements, secondary offerings, and other securities transactions. Her experience also includes advising on the formation and initial public offerings of special purpose acquisition companies (SPACs), business combination transactions, mergers and acquisitions involving public companies, including reverse mergers. She also advises domestic and foreign issuers on corporate governance, Exchange Act reporting obligations, and compliance with listing standards of the New York Stock Exchange (NYSE), Nasdaq, and FINRA.

Blessing has advised a wide range of clients, including public companies, investment funds, private equity and venture capital investors, emerging growth companies, and nonprofit organizations. She has represented clients across industries, including technology, artificial intelligence, life sciences, healthcare, energy, real estate, manufacturing, transportation, restaurant and hospitality, retail, and consumer products and services.

Represented Trident Digital Tech Holdings Ltd (Nasdaq: TDTH), a digital infrastructure holding company focused on building and operating sovereign-scale technology platforms across emerging markets, in its $8 million private placement of 20,000,000 Class B ordinary shares.

Represented Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical biotechnology company developing a novel and patented systemically administered anti-cancer and anti-viral immunotherapy, in an at-the-market equity offering program under which the Company may offer and sell, from time to time, its shares of Common Stock having an aggregate offering price of up to $100 million.

Represented a group of high net worth investors in their acquisition of a controlling block of preferred stock of a clinical stage biotechnology company whose securities are registered on Nasdaq Capital Market. The aggregate purchase price was $11.2 million.

Represented LQR House Inc. (NASDAQ: YHC), a niche ecommerce platform specializing in the spirits and beverage industry, in its $6.52 million registered direct offering with investors and certain directors and officers of the Company. A.G.P./Alliance Global Partners acted as the sole placement agent for the offering.

Represented Inno Holdings Inc. (NASDAQ: INHD), a trade-focused building technology and electronic products trading company, in its $7.2 million registered direct offering with institutional investors. Aegis Capital Corp. acted as exclusive placement agent for the offering.